Seattle Genetics was founded by a group of scientists and doctors, among them is Clay Siegall. The company was started in 1998 for purposes of promoting research. Clay Siegall is the company’s chief executive. He also sits on the board of directors. Owing to his leadership, the company has been able to secure $1.2 billion for research from private individuals and businesses.
As the chief executive of Seattle Genetics, Siegall has spear headed the development of antibody medication. It was in 2011 when the company was permitted to develop ADCENTRIS, a product that is now used as many as 60 countries. The FDA convinced of the potential of Seattle genetics allowed the company to produce this medication. With Siegall partnering with Takeda Pharmaceuticals, the drugs are reaching more and more people.
Owing to his influence and work in the field of science, Clay Siegall has been awarded severally. In 2013, ‘University of Maryland’ awarded Clay the ‘Alumnus of the Year’ prize for his work in science. Clay is also humbled by the ‘Ernest &Young Entrepreneur of the Year Award’. He is a respected writer with 15 patents so far.
Clay Siegall is a Zoology graduate from ‘University of Maryland’. As a scientist and researcher, he went back to school to study DNA and graduated with a Ph.D from ‘George Washington University’ in Genetics.
Siegall talks about the negative effects of confining inmates. In this state of confinement Siegall shows that these inmates long for communion with their fellow prisoners and crave for the touch of another individual at least. The confinement makes the prisoners unable to truck days, time and other such things. Debate has raged on about the negative effects solitary confinement has on inmates.
Another of Siegall’s posts demonstrates the dilemma of the US military as it tries to establish if there exists any risk to the troops who use ‘heavy firing machines’. The possibility that these machines affect the brain is being researched, but the hot gases emitted by the machines seem to point to a danger of brain damage.